X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

MOR

Closed

Morphosys Ag Adr

18.96
+18.96 (0%)
Last Update: 09 Aug 2024 16:30:00
Yesterday: 0.
Day's Range: 18.96 - 18.96
Send
When Written:
 
4.93
MorphoSys AG ADR is a German biopharmaceutical company that specializes in the development of therapeutic antibodies for the treatment of cancer, autoimmune disorders, and infectious diseases. The company's lead product is MOR208, a monoclonal antibody that targets CD19, a protein found on the surface of B-cells. MOR208 is currently in clinical trials for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

MorphoSys AG ADR is listed on the NASDAQ stock exchange under the ticker symbol "MOR". The company was founded in 1992 and is headquartered in Planegg, Germany. MorphoSys AG ADR has partnerships with several pharmaceutical companies, including Novartis, Roche, and Bayer, to develop and commercialize its products. The company has a strong pipeline of potential therapies, including MOR202, a monoclonal antibody for the treatment of multiple myeloma, and MOR107, a monoclonal antibody for the treatment of inflammatory diseases.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X